STUDY OF THE ADDED VALUE OF A TRANSMURAL EVALUATION IN PATIENTS WITH CROHN'S DISEASE UNDER BIOTHERAPY WITH CLOSE FECAL CALPROTECTIN FOLLOW-UP

NCT04973423 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Crohn Disease
Calprotectin
MRI

Interventions

RADIATION: MRI

Sponsor

University Hospital, Clermont-Ferrand